Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial
- DOI
- 10.1158/1078-0432.ccr-25-4356
- Published
- 2026-06-01
- Container
- Clinical Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-25-4356,
title = {Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial},
author = {Jonathan McConathy and Vadim S. Koshkin and Yusuf Menda and Jordi Rodon and Ajit H. Goenka and Ryan H. Moy and Sophie Morse and Arnaud Demange and Lars Blumenstein and Burcu Babaoglan and Paola Aimone and Thomas A. Hope},
year = {2026},
journal = {Clinical Cancer Research},
doi = {10.1158/1078-0432.ccr-25-4356},
url = {https://doi.org/10.1158/1078-0432.ccr-25-4356}
}RIS
TY - JOUR TI - Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial AU - Jonathan McConathy AU - Vadim S. Koshkin AU - Yusuf Menda AU - Jordi Rodon AU - Ajit H. Goenka AU - Ryan H. Moy AU - Sophie Morse AU - Arnaud Demange AU - Lars Blumenstein AU - Burcu Babaoglan AU - Paola Aimone AU - Thomas A. Hope PY - 2026 JO - Clinical Cancer Research DO - 10.1158/1078-0432.ccr-25-4356 UR - https://doi.org/10.1158/1078-0432.ccr-25-4356 ER -
APA
McConathy, J., Koshkin, V. S., Menda, Y., Rodon, J., Goenka, A. H., Moy, R. H., Morse, S., Demange, A., Blumenstein, L., Babaoglan, B., Aimone, P., & Hope, T. A. (2026). Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-4356
Source records
- crossref · retrieved 2026-09-27T08:18:40.026Z